For example, hepatic lipid accumulation may have contributed to impaired IGF‐1 production in the participants with obesity, as circulating IGF‐1 levels are reduced in those with hepatic steatosis (Mallea‐Gil et al., 2012). Here, IGF1 is linked to fatty liver disease.